The BPO and healthcare solutions firm rallies on strong earnings, guidance upgrades, and AI-driven growth optimism; analysts see sustained upside despite short-term consolidation.
By S JHA
Mumbai, November 1, 2025 — Shares of Sagility Ltd have surged nearly 21% in the past month, buoyed by a robust Q2FY26 earnings report, upbeat brokerage commentary, and rising investor confidence in the company’s AI-led growth strategy.
The stock, currently trading around ₹54.58, has climbed sharply from ₹42, marking a strong uptrend. Investor Arepalli Kiran noted on X, “The stock price has shown a clear and strong upward trend, rising from approximately ₹42 to ₹54.58.”
According to Business Upturn, Sagility shares rallied over 9% after the company reported a 68.9% QoQ jump in net profit to ₹251 crore and a 7.8% rise in revenue to ₹1,658 crore.
Market analyst Aadesh Jain said, “Sagility has delivered superb results again. Many were selling due to tariff war fears — had highlighted multiple times it has no relation. Hoping it should cross all-time highs soon.”
Investor sentiment turned particularly bullish after ICICI Securities reiterated a ‘BUY’ rating on the stock with a target price of ₹65, citing strong guidance and operational performance. The brokerage highlighted Sagility’s FY26 revenue growth forecast of 21%+, EBITDA margins of 25%, and plans to clear all external borrowings by FY27.
The company also announced its first dividend since listing, showing confidence in cash flows. Analysts point to robust hiring — over 4,300 recruits in H1FY26 — and growing AI adoption across 25 use cases as major structural positives.
While short-term traders expect the stock to consolidate between ₹45–₹52, long-term investors remain optimistic. “Sagility’s fundamentals are solid,” wrote Abhishek Bansal, “and with management maintaining this growth rate, further repricing toward mid-50s and beyond is likely.”
With strong financials, debt discipline, and GenAI integration, analysts hope that Sagility’s rally may just be the start of a longer-term re-rating story in India’s tech-enabled healthcare services space. Screener’s description for the company reads as: “Incorporated in July 2021, Sagility India Limited (formerly Berkmeer India Pvt. Ltd) provides healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.”
The face value of the stock is ₹10. The RoE and RoCE of Sagility stand at 7.38 and 9.58 respectively. The market cap of the company currently stands at ₹24596 crores.
(This article makes no recommendation for buy or sell of shares of any company)
Follow The Raisina Hills on WhatsApp, Instagram, YouTube, Facebook, and LinkedIn
